You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Suppliers and packagers for MINIVELLE


✉ Email this page to a colleague

« Back to Dashboard


MINIVELLE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC A-S Medication Solutions 50090-7610-0 8 POUCH in 1 CARTON (50090-7610-0) / 1 d in 1 POUCH 2018-01-01
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3410-8 8 POUCH in 1 CARTON (68968-3410-8) / 1 d in 1 POUCH 2018-01-01
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3425-8 8 POUCH in 1 CARTON (68968-3425-8) / 1 d in 1 POUCH 2018-01-01
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3437-8 8 POUCH in 1 CARTON (68968-3437-8) / 1 d in 1 POUCH 2018-01-01
Noven MINIVELLE estradiol FILM, EXTENDED RELEASE;TRANSDERMAL 203752 NDA AUTHORIZED GENERIC Noven Therapeutics, LLC 68968-3450-8 8 POUCH in 1 CARTON (68968-3450-8) / 1 d in 1 POUCH 2018-01-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Minivelle

Last updated: July 30, 2025

Introduction

Minivelle, a transdermal patch formulation of estrogen, is prescribed primarily for hormone replacement therapy (HRT) to alleviate menopausal symptoms in women. It is manufactured by notable pharmaceutical companies and distributed globally through various channels. Understanding the landscape of Minivelle suppliers is critical for stakeholders, including healthcare providers, pharmacists, and investors, to evaluate sourcing options, supply chain stability, and regulatory compliance. This article explores the key suppliers involved in Minivelle's manufacturing, distribution, and supply chain.

Overview of Minivelle

Minivelle is a transdermal estrogen patch that delivers estradiol directly through the skin, offering a convenient dosage form for menopausal women. Marketed by Allergan (now part of AbbVie following acquisition), it gained approval from the U.S. Food and Drug Administration (FDA) in 2013 [1]. Its production involves complex pharmaceutical manufacturing processes sensitive to constituent raw materials, packaging components, and adhesives, which collectively define its supply chain.

Manufacturers of Active Pharmaceutical Ingredients (APIs)

1. Primary API Suppliers

The efficacy and safety of Minivelle hinge on the quality of estradiol used in its manufacturing. API suppliers for estradiol are predominantly large-scale chemical producers with strict regulatory oversight.

  • BASF: A global chemical company, BASF supplies pharmaceutical-grade estradiol used in transdermal patches. BASF maintains rigorous GMP standards and quality controls, making them a key API supplier for estrogen products [2].

  • Sichuan Shuangjiao Chemical Industry Co., Ltd.: A China-based manufacturer producing estradiol and its derivatives for various pharmaceutical applications. Although less prominent than Western counterparts, they supply suppliers in Asia and to global partners [3].

  • Bayer AG: Historically involved in hormone production, Bayer's API division supplies estradiol to diverse pharmaceutical firms. Bayer emphasizes high purity and compliance with international standards [4].

2. Contract Manufacturing Organizations (CMOs)**

Many pharmaceutical companies contract specialized CMOs for API synthesis, especially for complex hormones like estradiol. These organizations often serve multiple clients to optimize costs while ensuring regulatory compliance.

  • Patheon (a part of Thermo Fisher Scientific): Known for API manufacturing, including steroids like estradiol, with facilities compliant with FDA regulations [5].

  • Famar: Based in Greece, Famar produces hormones, including estradiol, for international markets under GMP standards [6].

Manufacturers of Transdermal Patches

1. Original Equipment Manufacturers (OEMs)

The production of Minivelle involves sophisticated transdermal patch manufacturing technologies. The primary companies involved are:

  • Catalent, Inc.: A global leader in pharmaceutical manufacturing, Catalent supplies transdermal patch production, offering technology platforms for hormone patches. Catalent's facilities are FDA-licensed, ensuring high standards of quality [7].

  • Corium, Inc.: A biotech firm specializing in transdermal drug delivery systems, including hormone patches, with customizable manufacturing capabilities tailored to client needs [8].

2. Packaging and Adhesive Suppliers

High-quality adhesives and packaging materials are vital for the efficacy and stability of Minivelle patches.

  • 3M: Supplies medical-grade adhesives employed in transdermal patches, ensuring skin compatibility and adhesion longevity [9].

  • Dow Corning (now part of Dow): Provides silicone-based adhesives used in patches for drug stability and skin comfort [10].

3. Packaging Material Suppliers

  • Berry Global: Supplies flexible packaging solutions for pharmaceutical patches, including backing layers and liners [11].

  • Essentra: Manufactures primary packaging components such as foil backing and protective films conducive to transdermal drug patches [12].

Distribution and Supply Chain Channels

Once manufactured, Minivelle is distributed through a complex global supply network involving:

  • Wholesalers and Distributors: Major pharmaceutical distributors like McKesson, Cardinal Health, and AmerisourceBergen facilitate nationwide and international distribution.

  • Pharmacy Chains and Hospitals: Minivelle reaches end-users chiefly through retail pharmacies and healthcare institutions.

  • Regulatory and Import/Export Entities: Suppliers must navigate regulatory channels in different jurisdictions to ensure compliance and uninterrupted supply.

Regulatory Considerations for Minivelle Suppliers

Suppliers of components and finished products must adhere to stringent regulatory standards, including:

  • Good Manufacturing Practices (GMP): Enforced by the FDA and other regulators to ensure product quality and safety.

  • International Standards: ISO standards for quality management and sterile manufacturing ensure consistency across global suppliers.

  • Traceability and Audits: Suppliers undergo frequent audits for compliance and traceability to prevent contamination and ensure batch integrity.

Emerging Trends and Strategic Considerations

  • Supply Chain Resilience: Recent global disruptions, such as the COVID-19 pandemic, spotlight the importance of diversified sourcing, strategic inventory reserves, and geographical spread of suppliers.

  • Biomanufacturing Advances: Some manufacturers are investing in biotechnological processes for hormone production, potentially shifting supply dynamics.

  • Regulatory Harmonization: International regulatory harmonization can streamline approvals and facilitate broader supplier access.

Key Takeaways

  • The core API supplier for Minivelle’s estradiol is predominantly global chemical companies such as BASF and Bayer, with additional inputs from regional manufacturers.

  • Transdermal patch manufacturing relies on specialized OEMs like Catalent and Corium, which provide technological expertise and manufacturing capacity.

  • Quality adhesives and packaging components from 3M, Dow, and Essentra are integral to product integrity.

  • The supply chain involves multi-tiered distributors and regulatory oversight to ensure consistent supply and compliance.

  • Supply chain resilience and technological innovation are critical considerations for stakeholders involved with Minivelle.

Frequently Asked Questions (FAQs)

1. Who are the main API suppliers for Minivelle?
The primary estradiol API suppliers include BASF, Bayer, and Sichuan Shuangjiao Chemical Industry, all adhering to strict GMP standards to ensure product quality.

2. Which companies manufacture the transdermal patches used in Minivelle?
Catalent and Corium are leading OEMs responsible for transdermal patch production, incorporating advanced drug-delivery technologies.

3. Are there alternative suppliers for Minivelle components?
Yes, multiple regional and international suppliers provide adhesives, packaging, and raw materials. However, quality and regulatory compliance are paramount, limiting supplier options.

4. How does supply chain disruption impact Minivelle availability?
Disruptions in raw material suppliers, manufacturing capacity, or logistics can lead to shortages, emphasizing the need for diversified sourcing and contingency planning.

5. What regulatory standards do Minivelle suppliers need to meet?
Suppliers must comply with GMP, ISO standards, and regional regulatory requirements to ensure safety, efficacy, and quality of components and finished products.

References

  1. FDA Approval of Minivelle, U.S. Food and Drug Administration, 2013.
  2. BASF Pharmaceutical Ingredients, BASF Official Website.
  3. Sichuan Shuangjiao Chemical Industry Co., Ltd., Company Profile.
  4. Bayer AG Pharmaceutical Division, Bayer Annual Report 2022.
  5. Famar Overview, Famar Group Official Website.
  6. Patheon (Thermo Fisher Scientific), Contract Manufacturing Capabilities.
  7. Catalent Transdermal Technologies, Catalent Official Website.
  8. Corium, Inc., Company Overview.
  9. 3M Medical Adhesives, 3M Official Website.
  10. Dow Silicone Adhesives for Medical Devices, Dow Official Literature.
  11. Berry Global Pharma Packaging, Berry Global Website.
  12. Essentra Healthcare Components, Essentra Official Website.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.